Forbes contributors publish independent expert analyses and insights. I write about health and U.K. health policy. Feb 22, 2025, 09:20am EST Flying bat action shot of hunting animal in natural forest ...

World Health Organization officials first learned about a cluster of cases of pneumonia in the Hubei Province of China on Dec. 31, 2019. This represented the initial report of what soon became known ...

The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants ...

FDA approves Shionogi’s Xocova as First Oral Post-Exposure Covid-19 Prevention Therapy, marking a major milestone for Covid-19 prevention treatments. FDA has approved Shionogi’s Xocova (ensitrelvir) ...

Maternal COVID-19 vaccination during pregnancy, particularly in the third trimester, lowers infant risk for COVID-19 infection and hospitalization.

FDA approves ensitrelvir for COVID-19 postexposure prophylaxis following phase 3 data showing efficacy against Omicron symptoms. The FDA recently approved ensitrelvir (Xocova; Shionogi), an ...

A new variant of the SARS-CoV-2 virus, dubbed Cicada, is less susceptible to vaccination and appears to discriminate based on age, according to scientists. The variant appears les ...

Those who’ve dodged COVID-19 for more than four years may have a newly discovered immune response to thank. The results stem from a challenge trial: At the height of the pandemic in 2021, scientists ...

The FDA has approved Shionogi's Xocova (ensitrelvir) for post-exposure prevention of Covid-19 in adults and adolescents aged ...